<?xml version="1.0" encoding="UTF-8"?>
<ref id="B63" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Schumann</surname>
    <given-names class="given-names">B.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Winkler</surname>
    <given-names class="given-names">J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Mickenautsch</surname>
    <given-names class="given-names">N.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Warnken</surname>
    <given-names class="given-names">T.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Dänicke</surname>
    <given-names class="given-names">S.</given-names>
   </name>
  </person-group> (
  <year class="year">2016</year>). 
  <article-title class="article-title">Effects of deoxynivalenol (DON), zearalenone (ZEN), and related metabolites on equine peripheral blood mononuclear cells (PBMC) 
   <italic class="italic">in vitro</italic> and background occurrence of these toxins in horses
  </article-title>. 
  <source class="source">Mycotoxin Res.</source>
  <volume class="volume">32</volume>, 
  <fpage class="fpage">153</fpage>–
  <lpage class="lpage">161</lpage>. 
  <pub-id pub-id-type="doi" class="pub-id">10.1007/s12550-016-0250-1</pub-id>
  <?supplied-pmid 27255919?>
  <pub-id pub-id-type="pmid" class="pub-id">27255919</pub-id>
 </mixed-citation>
</ref>
